Compass Minerals International Downgraded to Underweight by JP Morgan with PT Raised to $18.
ByAinvest
Wednesday, Aug 13, 2025 6:47 am ET1min read
CMP--
The downgrade is based on JPMorgan's expectations that Compass Minerals will report approximately 6% lower EBITDA in fiscal year 2025 compared to fiscal 2024, with estimates of $194 million versus $206 million previously [1]. The company's current EBITDA stands at $140.1 million, and the stock is currently undervalued based on its Fair Value model [1].
JPMorgan noted that Compass Minerals began its fiscal year slowly due to weak snowfall patterns, though earnings later accelerated as snowfall levels strengthened and the company made operational progress in its Plant Nutrition business [1]. Despite the downgrade, the firm highlighted that Compass has been a strong generator of free cash flow in fiscal 2025 through working capital benefits from inventory reduction, projecting almost a 17% free cash flow yield for the year [1].
The bank expects Compass to reduce its net leverage from 4.5x at the end of fiscal 2024 to 4.1x by fiscal year-end 2025, with potential for approximately 17% EBITDA growth to $227 million in fiscal 2026 as the company compares against what JPMorgan anticipates will be a very weak first quarter of fiscal 2025 [1].
Compass Minerals recently reported mixed financial results for its fiscal 2025 third quarter. The company achieved revenue of $214.6 million, surpassing analyst expectations of $207.61 million. This marks a 5.8% increase in revenue compared to the same quarter last year, attributed to higher sales volumes in both the Salt and Plant Nutrition segments. However, Compass Minerals reported an adjusted loss of -$0.39 per share, falling short of analyst estimates of a -$0.01 loss [2, 3].
Despite the earnings miss, the company anticipates improvements in pricing moving forward. These recent developments come as Compass Minerals continues to navigate the challenges in its industry [3]. The stock gained 1.85% post-earnings but underperformed a 49.76% benchmark return for 30-day buy-and-hold strategies, reflecting cautious market sentiment [4].
References:
[1] https://www.investing.com/news/analyst-ratings/jpmorgan-downgrades-compass-minerals-stock-rating-to-underweight-on-weaker-ebitda-outlook-93CH-4187124
[2] https://www.tradingview.com/news/reuters.com,2025:newsml_L8N3U31NA:0-compass-minerals-international-inc-reports-results-for-the-quarter-ended-june-30-earnings-summary/
[3] https://www.investing.com/news/earnings/compass-minerals-posts-mixed-q3-results-expects-improvements-in-pricing-93CH-4183856
[4] https://www.ainvest.com/news/compass-minerals-international-2025-q3-earnings-narrowed-losses-revenue-growth-2508/
JPM--
Compass Minerals International Downgraded to Underweight by JP Morgan with PT Raised to $18.
JP Morgan has downgraded Compass Minerals International (NYSE:CMP) from Overweight to Underweight, while raising its price target to $18.00 from $15.00 [1]. The investment bank's decision comes despite the stock's remarkable 86.5% return over the past year, currently trading at $19.21 [1].The downgrade is based on JPMorgan's expectations that Compass Minerals will report approximately 6% lower EBITDA in fiscal year 2025 compared to fiscal 2024, with estimates of $194 million versus $206 million previously [1]. The company's current EBITDA stands at $140.1 million, and the stock is currently undervalued based on its Fair Value model [1].
JPMorgan noted that Compass Minerals began its fiscal year slowly due to weak snowfall patterns, though earnings later accelerated as snowfall levels strengthened and the company made operational progress in its Plant Nutrition business [1]. Despite the downgrade, the firm highlighted that Compass has been a strong generator of free cash flow in fiscal 2025 through working capital benefits from inventory reduction, projecting almost a 17% free cash flow yield for the year [1].
The bank expects Compass to reduce its net leverage from 4.5x at the end of fiscal 2024 to 4.1x by fiscal year-end 2025, with potential for approximately 17% EBITDA growth to $227 million in fiscal 2026 as the company compares against what JPMorgan anticipates will be a very weak first quarter of fiscal 2025 [1].
Compass Minerals recently reported mixed financial results for its fiscal 2025 third quarter. The company achieved revenue of $214.6 million, surpassing analyst expectations of $207.61 million. This marks a 5.8% increase in revenue compared to the same quarter last year, attributed to higher sales volumes in both the Salt and Plant Nutrition segments. However, Compass Minerals reported an adjusted loss of -$0.39 per share, falling short of analyst estimates of a -$0.01 loss [2, 3].
Despite the earnings miss, the company anticipates improvements in pricing moving forward. These recent developments come as Compass Minerals continues to navigate the challenges in its industry [3]. The stock gained 1.85% post-earnings but underperformed a 49.76% benchmark return for 30-day buy-and-hold strategies, reflecting cautious market sentiment [4].
References:
[1] https://www.investing.com/news/analyst-ratings/jpmorgan-downgrades-compass-minerals-stock-rating-to-underweight-on-weaker-ebitda-outlook-93CH-4187124
[2] https://www.tradingview.com/news/reuters.com,2025:newsml_L8N3U31NA:0-compass-minerals-international-inc-reports-results-for-the-quarter-ended-june-30-earnings-summary/
[3] https://www.investing.com/news/earnings/compass-minerals-posts-mixed-q3-results-expects-improvements-in-pricing-93CH-4183856
[4] https://www.ainvest.com/news/compass-minerals-international-2025-q3-earnings-narrowed-losses-revenue-growth-2508/
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet